In last trading session, Cocrystal Pharma Inc (NASDAQ:COCP) saw 60847.0 shares changing hands with its beta currently measuring 1.54. Company’s recent per share price level of $2.41 trading at $0.15 or 6.50% at ring of the bell on the day assigns it a market valuation of $24.49M. That closing price of COCP’s stock is at a discount of -35.27% from its 52-week high price of $3.26 and is indicating a premium of 44.81% from its 52-week low price of $1.33. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 42.50K if we extend that period to 3-months.
For Cocrystal Pharma Inc (COCP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Cocrystal Pharma Inc (NASDAQ:COCP) trade information
Upright in the green during last session for gaining 6.50%, in the last five days COCP remained trading in the green while hitting it’s week-highest on Wednesday, 01/08/25 when the stock touched $2.41 price level, adding 7.31% to its value on the day. Cocrystal Pharma Inc’s shares saw a change of 19.16% in year-to-date performance and have moved 19.16% in past 5-day. Cocrystal Pharma Inc (NASDAQ:COCP) showed a performance of 26.68% in past 30-days. Number of shares sold short was 1988.0 shares which calculate 0.12 days to cover the short interests.
Cocrystal Pharma Inc (COCP) estimates and forecasts
Statistics highlight that Cocrystal Pharma Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 5.11% of value to its shares in past 6 months, showing an annual growth rate of -2.14% while that of industry is 17.00. Apart from that, the company came lowering its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -1.25% during past 5 years.
Cocrystal Pharma Inc (NASDAQ:COCP)’s Major holders
Insiders are in possession of 31.85% of company’s total shares while institution are holding 6.94 percent of that, with stock having share float percentage of 10.19%. Investors also watch the number of corporate investors in a company very closely, which is 6.94% institutions for Cocrystal Pharma Inc that are currently holding shares of the company.
